Need help? Text us, and a team member will reply help@aminosociety.org Need help? Text us, and a team member will reply help@aminosociety.org Need help? Text us, and a team member will reply help@aminosociety.org

In Stock

Amino Society GLP-3(RT) 10mg research peptide vial
≥99% Purity · HPLC verified

Research Use Only

GLP3-RT (Retatrutide)

What is GLP3-RT (Retatrutide)? Retatrutide is a synthetic 39 amino acid triple agonist peptide targeting the GIP receptor, GLP-1 receptor, and glucagon receptor simultaneously. This unimolecular triple agonist design adds glucagon receptor activation to the incretin synergy of dual agonists. Studied…
Select Size or Weight
1 VIAL
2 VIALS Save 5%
3+ VIALS Save 10%
≥99% Purity

HPLC verified

Lab tested

HPLC + MS

Same-day ship

Order by 2pm
PT

  • FREE shipping on orders over $200
  • Same-day dispatch if ordered before 2pm EST (Mon-Fri)
  • Estimated delivery: 2-3 business days via USPS Priority Mail
CERTIFICATE OF ANALYSIS THIRD-PARTY VERIFIED BY HPLC & MASS SPECTROMETRY
VIEW COA
Products

Recommended Research Stacks Research Stacks Research Stacks

Amino Society KPV 10mg research peptide vial

kpv

$99.99
Amino Society SS-31 10mg research peptide vial

SS-31

$89.99
Amino Society KISSPEPTIN-10 10mg research peptide vial

KISSPEPTIN-10

$94.99
Amino Society PT-141 10mg research peptide vial

PT-141

$84.99
Amino Society BPC157 10mg research peptide vial

BPC-157

$99.99
Amino Society GHK_Cu 100mg research peptide vial

GHK-Cu

$80.00
Identity

Compound Information Information Information

GLP3-RT (Retatrutide) Overview

Retatrutide is a synthetic peptide studied as a triple agonist acting on GLP-1, GIP, and glucagon receptors simultaneously. It is one of the most extensively studied next-generation incretin-pathway research compounds, combining three metabolic signaling targets in one molecule.
CAS Number
2381089-83-2
Molecular Formula
C221H342N46O68
Molecular Weight
4731.33 g/mol
Composition
Synthetic triple agonist peptide targeting GLP-1, GIP, and glucagon receptors
Half-Life
Extended (multi-day), attributed to fatty-acid chain conjugation for albumin binding
Source
Synthetic (solid-phase peptide synthesis)
Purity
99.0% (HPLC Verified)
Form
Dual-cartridge pen (lyophilized compound + diluent in sealed cartridges, combined at time of use)
Solubility
Highly soluble in water, bacteriostatic water

History

Retatrutide was developed as researchers sought to combine the individually studied effects of GLP-1, GIP, and glucagon receptor agonism into a single molecule, building on structure-activity research into earlier dual and single-target incretin analogs.

Stability Information

Long-term

−20°C

Lyophilized powder, sealed

Reconstituted

2–8°C

Up to 30 days when refrigerated

Shipping

Room temp

Stable in transit, lyophilized

Protection

Light · Moisture

Store sealed, away from light

Research Findings

Retatrutide has been studied in laboratory, animal, and published clinical research models of energy metabolism, appetite-regulation signaling, and combined incretin/glucagon receptor pathways.

Key Areas of Research:

Metabolic
Combined GLP-1/GIP/glucagon receptor research
Endocrine
Incretin pathway signaling studies
Clinical Research
Extensively documented in published literature

Together, these findings support Retatrutide's position as a leading research compound for studying multi-receptor metabolic signaling pathways.

Important Safety Information

All products are sold strictly for in-vitro research and laboratory use only. Not for human or veterinary consumption, ingestion, injection, inhalation, application to the skin, or any other clinical use. Not approved by the FDA for any therapeutic purpose. Intended exclusively for qualified researchers in a controlled laboratory environment. By purchasing, you acknowledge and agree to use this material in compliance with all applicable laws and your institutional protocols.